Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Pediatric MRI Sedation
NCT05192629Phase 3Unknown
- Sponsor
- CHU Brugmann
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine, sponsored by CHU Brugmann. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT05192629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05192629.